These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33057670)

  • 21. Cerebral cortical thickness and gyrification changes in first-episode psychoses and multi-episode schizophrenia.
    Del Casale A; Rossi-Espagnet MC; Napolitano A; Lucignani M; Bonanni L; Kotzalidis GD; Buscajoni A; Manelfi L; Perrone V; Gualtieri I; Brugnoli R; De Pisa E; Girardi P; Romano A; Ferracuti S; Bozzao A; Pompili M
    Arch Ital Biol; 2021 Mar; 159(1):3-20. PubMed ID: 34159573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia.
    Lesh TA; Tanase C; Geib BR; Niendam TA; Yoon JH; Minzenberg MJ; Ragland JD; Solomon M; Carter CS
    JAMA Psychiatry; 2015 Mar; 72(3):226-34. PubMed ID: 25588194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural similarity networks predict clinical outcome in early-phase psychosis.
    Homan P; Argyelan M; DeRosse P; Szeszko PR; Gallego JA; Hanna L; Robinson DG; Kane JM; Lencz T; Malhotra AK
    Neuropsychopharmacology; 2019 Apr; 44(5):915-922. PubMed ID: 30679724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness.
    Torres US; Duran FL; Schaufelberger MS; Crippa JA; Louzã MR; Sallet PC; Kanegusuku CY; Elkis H; Gattaz WF; Bassitt DP; Zuardi AW; Hallak JE; Leite CC; Castro CC; Santos AC; Murray RM; Busatto GF
    Neuroimage Clin; 2016; 12():1-15. PubMed ID: 27354958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical surface abnormalities are different depending on the stage of schizophrenia: A cross-sectional vertexwise mega-analysis of thickness, area and gyrification.
    Rosa PGP; Zugman A; Cerqueira CT; Serpa MH; de Souza Duran FL; Zanetti MV; Bassitt DP; Elkis H; Crippa JAS; Sallet PC; Gattaz WF; Hallak JEC; Louzã MR; Gadelha A; Jackowski AP; Bressan RA; Filho GB
    Schizophr Res; 2021 Oct; 236():104-114. PubMed ID: 34481405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced connectivity in anterior cingulate cortex as an early predictor for treatment response in drug-naive, first-episode schizophrenia: A global-brain functional connectivity analysis.
    Li H; Ou Y; Liu F; Chen J; Zhao J; Guo W; Fan X
    Schizophr Res; 2020 Jan; 215():337-343. PubMed ID: 31522869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Risperidone Monotherapy on Dynamic Functional Connectivity of Insular Subdivisions in Treatment-Naive, First-Episode Schizophrenia.
    Duan X; Hu M; Huang X; Su C; Zong X; Dong X; He C; Xiao J; Li H; Tang J; Chen X; Chen H
    Schizophr Bull; 2020 Apr; 46(3):650-660. PubMed ID: 31504959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia.
    Takahashi T; Wood SJ; Soulsby B; McGorry PD; Tanino R; Suzuki M; Velakoulis D; Pantelis C
    Schizophr Res; 2009 Mar; 108(1-3):49-56. PubMed ID: 19171466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local gyrification index in probands with psychotic disorders and their first-degree relatives.
    Nanda P; Tandon N; Mathew IT; Giakoumatos CI; Abhishekh HA; Clementz BA; Pearlson GD; Sweeney J; Tamminga CA; Keshavan MS
    Biol Psychiatry; 2014 Sep; 76(6):447-55. PubMed ID: 24369266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortical thickness reduction in individuals at ultra-high-risk for psychosis.
    Jung WH; Kim JS; Jang JH; Choi JS; Jung MH; Park JY; Han JY; Choi CH; Kang DH; Chung CK; Kwon JS
    Schizophr Bull; 2011 Jul; 37(4):839-49. PubMed ID: 20026559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortical Contributions to Distinct Symptom Dimensions of Catatonia.
    Hirjak D; Kubera KM; Northoff G; Fritze S; Bertolino AL; Topor CE; Schmitgen MM; Wolf RC
    Schizophr Bull; 2019 Oct; 45(6):1184-1194. PubMed ID: 30753720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive brain changes in children and adolescents with first-episode psychosis.
    Arango C; Rapado-Castro M; Reig S; Castro-Fornieles J; González-Pinto A; Otero S; Baeza I; Moreno C; Graell M; Janssen J; Parellada M; Moreno D; Bargalló N; Desco M
    Arch Gen Psychiatry; 2012 Jan; 69(1):16-26. PubMed ID: 22213785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive insight is associated with cortical thickness in first-episode psychosis.
    Buchy L; Barbato M; MacMaster FP; Bray S; Clark D; Deighton S; Addington J
    Schizophr Res; 2016 Apr; 172(1-3):16-22. PubMed ID: 26899212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adolescent vs. adult onset of a first episode psychosis: Impact on remission of positive and negative symptoms.
    Veru F; Jordan G; Joober R; Malla A; Iyer S
    Schizophr Res; 2016 Jul; 174(1-3):183-188. PubMed ID: 27102425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.
    Plitman E; Patel R; Chung JK; Pipitone J; Chavez S; Reyes-Madrigal F; Gómez-Cruz G; León-Ortiz P; Chakravarty MM; de la Fuente-Sandoval C; Graff-Guerrero A
    Neuropsychopharmacology; 2016 Sep; 41(10):2606-13. PubMed ID: 27272768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss.
    Price G; Cercignani M; Chu EM; Barnes TR; Barker GJ; Joyce EM; Ron MA
    Neuroimage; 2010 Jan; 49(1):185-92. PubMed ID: 19632338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis.
    Dazzan P; Soulsby B; Mechelli A; Wood SJ; Velakoulis D; Phillips LJ; Yung AR; Chitnis X; Lin A; Murray RM; McGorry PD; McGuire PK; Pantelis C
    Schizophr Bull; 2012 Sep; 38(5):1083-91. PubMed ID: 21518921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimaging biomarkers to predict treatment response in schizophrenia: the end of 30 years of solitude?
    Dazzan P
    Dialogues Clin Neurosci; 2014 Dec; 16(4):491-503. PubMed ID: 25733954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortical morphology of adolescents with bipolar disorder and with schizophrenia.
    Janssen J; Alemán-Gómez Y; Schnack H; Balaban E; Pina-Camacho L; Alfaro-Almagro F; Castro-Fornieles J; Otero S; Baeza I; Moreno D; Bargalló N; Parellada M; Arango C; Desco M
    Schizophr Res; 2014 Sep; 158(1-3):91-9. PubMed ID: 25085384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.
    Kahn RS; Winter van Rossum I; Leucht S; McGuire P; Lewis SW; Leboyer M; Arango C; Dazzan P; Drake R; Heres S; Díaz-Caneja CM; Rujescu D; Weiser M; Galderisi S; Glenthøj B; Eijkemans MJC; Fleischhacker WW; Kapur S; Sommer IE;
    Lancet Psychiatry; 2018 Oct; 5(10):797-807. PubMed ID: 30115598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.